United States · FDA National Drug Code directory
DEXAMETHASONE SODIUM PHOSPHATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51662-1370_ef7bd5a0-02a9-7b66-e053-2995a90a8ffa
- Product NDC
- 51662-1370
- Form
- INJECTION, SOLUTION
- Composition / generic term
- DEXAMETHASONE SODIUM PHOSPHATE
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191013
- Source listing expiry
- 20261231
Source-listed ingredients
- DEXAMETHASONE SODIUM PHOSPHATE — 4 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 mL in 1 VIAL, MULTI-DOSE (51662-1370-1) · 51662-1370-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →